Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab

Vincenzo Quagliariello,1,* Raffaele Vecchione,2,* Alberta De Capua,2 Elena Lagreca,2 Rosario Vincenzo Iaffaioli,3 Gerardo Botti,4 Paolo A Netti,2 Nicola Maurea1 1Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, Italia; 2Center for Advanced Biomaterial for Heal...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Quagliariello V, Vecchione R, De Capua A, Lagreca E, Iaffaioli RV, Botti G, Netti PA, Maurea N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	cardio-oncology nano-medicine coenzyme q10 doxorubicin trastuzumab inflammation Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a7acd3cdf2134e0f96f7813349242ca9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a7acd3cdf2134e0f96f7813349242ca9
record_format	dspace
spelling	oai:doaj.org-article:a7acd3cdf2134e0f96f7813349242ca92021-12-02T09:44:00ZNano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab1178-2013https://doaj.org/article/a7acd3cdf2134e0f96f7813349242ca92020-07-01T00:00:00Zhttps://www.dovepress.com/nano-encapsulation-of-coenzyme-q10-in-secondary-and-tertiary-nano-emul-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Vincenzo Quagliariello,1,* Raffaele Vecchione,2,* Alberta De Capua,2 Elena Lagreca,2 Rosario Vincenzo Iaffaioli,3 Gerardo Botti,4 Paolo A Netti,2 Nicola Maurea1 1Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, Italia; 2Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci 53, Naples, Italy; 3Multidisciplinary Studies in Oncology and Mediterranean Diet, Piazza Nicola Amore, Naples, Italy; 4Scientific Direction, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, Italia*These authors contributed equally to this workCorrespondence: Vincenzo QuagliarielloDivision of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, ItaliaTel +390815903349Email quagliariello.enzo@gmail.comIntroduction: CoenzymeQ10 (CoQ10) is a well-known antioxidant and anti-inflammatory agent with cardioprotective properties. However, clinical trials based on its oral administration have failed to provide significant effect on cardiac functionality. The main limitation of CoQ10 is based on its very low oral bioavailability and instability that limit dramatically its effects as a cardioprotective agent. Herein, we loaded CoQ10 in high bioavailable nano-emulsions (NEs) coated with chitosan or chitosan and hyaluronic acid in order to improve its performance.Methods: We tested cardioprotective and hepatoprotective effects of CoQ10-loaded nano-carriers against Doxorubicin and Trastuzumab toxicities in cardiomyocytes and liver cells through analysis of cell viability, lipid peroxidation, expression of leukotrienes, p65/NF-kB and pro-inflammatory cytokines involved in anticancer-induced cardio and hepatotoxicity.Results: Nano-carriers showed high stability and loading ability and increased cell viability both in hepatocytes and cardiomyocytes during anticancer treatments. We observed that these effects are mediated by the inhibition of lipid peroxidation and reduction of the inflammation. CoQ10-loaded nano-emulsions showed also strong anti-inflammatory effects reducing leukotriene B4 and p65/NF-κB expression and Interleukin 1β and 6 production during anticancer treatments.Discussion: Anthracyclines and Human epidermal growth factor receptor (HER2) inhibitors have shown significant anticancer effects in clinical practice but their use is characterized by cardiotoxicity and hepatotoxicity. Nano-carriers loaded with CoQ10 showed cardio and hepatoprotective properties mediated by reduction of oxidative damages and pro-inflammatory mediators. These results set the stage for preclinical studies of cardio and hepatoprotection in HER2+ breast cancer-bearing mice treated with Doxorubicin and Trastuzumab.Keywords: cardio-oncology, nano-medicine, Coenzyme Q10, doxorubicin, trastuzumab, inflammationQuagliariello VVecchione RDe Capua ALagreca EIaffaioli RVBotti GNetti PAMaurea NDove Medical Pressarticlecardio-oncologynano-medicinecoenzyme q10doxorubicintrastuzumabinflammationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 4859-4876 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	cardio-oncology nano-medicine coenzyme q10 doxorubicin trastuzumab inflammation Medicine (General) R5-920
spellingShingle	cardio-oncology nano-medicine coenzyme q10 doxorubicin trastuzumab inflammation Medicine (General) R5-920 Quagliariello V Vecchione R De Capua A Lagreca E Iaffaioli RV Botti G Netti PA Maurea N Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
description	Vincenzo Quagliariello,1,* Raffaele Vecchione,2,* Alberta De Capua,2 Elena Lagreca,2 Rosario Vincenzo Iaffaioli,3 Gerardo Botti,4 Paolo A Netti,2 Nicola Maurea1 1Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, Italia; 2Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci 53, Naples, Italy; 3Multidisciplinary Studies in Oncology and Mediterranean Diet, Piazza Nicola Amore, Naples, Italy; 4Scientific Direction, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, Italia*These authors contributed equally to this workCorrespondence: Vincenzo QuagliarielloDivision of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, Napoli, ItaliaTel +390815903349Email quagliariello.enzo@gmail.comIntroduction: CoenzymeQ10 (CoQ10) is a well-known antioxidant and anti-inflammatory agent with cardioprotective properties. However, clinical trials based on its oral administration have failed to provide significant effect on cardiac functionality. The main limitation of CoQ10 is based on its very low oral bioavailability and instability that limit dramatically its effects as a cardioprotective agent. Herein, we loaded CoQ10 in high bioavailable nano-emulsions (NEs) coated with chitosan or chitosan and hyaluronic acid in order to improve its performance.Methods: We tested cardioprotective and hepatoprotective effects of CoQ10-loaded nano-carriers against Doxorubicin and Trastuzumab toxicities in cardiomyocytes and liver cells through analysis of cell viability, lipid peroxidation, expression of leukotrienes, p65/NF-kB and pro-inflammatory cytokines involved in anticancer-induced cardio and hepatotoxicity.Results: Nano-carriers showed high stability and loading ability and increased cell viability both in hepatocytes and cardiomyocytes during anticancer treatments. We observed that these effects are mediated by the inhibition of lipid peroxidation and reduction of the inflammation. CoQ10-loaded nano-emulsions showed also strong anti-inflammatory effects reducing leukotriene B4 and p65/NF-κB expression and Interleukin 1β and 6 production during anticancer treatments.Discussion: Anthracyclines and Human epidermal growth factor receptor (HER2) inhibitors have shown significant anticancer effects in clinical practice but their use is characterized by cardiotoxicity and hepatotoxicity. Nano-carriers loaded with CoQ10 showed cardio and hepatoprotective properties mediated by reduction of oxidative damages and pro-inflammatory mediators. These results set the stage for preclinical studies of cardio and hepatoprotection in HER2+ breast cancer-bearing mice treated with Doxorubicin and Trastuzumab.Keywords: cardio-oncology, nano-medicine, Coenzyme Q10, doxorubicin, trastuzumab, inflammation
format	article
author	Quagliariello V Vecchione R De Capua A Lagreca E Iaffaioli RV Botti G Netti PA Maurea N
author_facet	Quagliariello V Vecchione R De Capua A Lagreca E Iaffaioli RV Botti G Netti PA Maurea N
author_sort	Quagliariello V
title	Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
title_short	Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
title_full	Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
title_fullStr	Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
title_full_unstemmed	Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab
title_sort	nano-encapsulation of coenzyme q10 in secondary and tertiary nano-emulsions for enhanced cardioprotection and hepatoprotection in human cardiomyocytes and hepatocytes during exposure to anthracyclines and trastuzumab
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/a7acd3cdf2134e0f96f7813349242ca9
work_keys_str_mv	AT quagliariellov nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT vecchioner nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT decapuaa nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT lagrecae nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT iaffaiolirv nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT bottig nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT nettipa nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab AT maurean nanoencapsulationofcoenzymeq10insecondaryandtertiarynanoemulsionsforenhancedcardioprotectionandhepatoprotectioninhumancardiomyocytesandhepatocytesduringexposuretoanthracyclinesandtrastuzumab
_version_	1718398023918157824

Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab

Ejemplares similares